Mercury Biopharmaceutical Corporation (TPEX: 6932)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.25
+0.10 (0.76%)
Nov 20, 2024, 9:16 AM CST

Mercury Biopharmaceutical Market Cap

Mercury Biopharmaceutical has a market cap or net worth of 5.51 billion as of November 22, 2024. Its market cap has decreased by -34.09% in one year.

Market Cap
5.51B
Enterprise Value
5.29B
Revenue
5.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.25

Market Cap Chart

Since December 23, 2022, Mercury Biopharmaceutical's market cap has increased from 5.10B to 5.51B, an increase of 7.96%. That is a compound annual growth rate of 4.08%.

History

DateMarket Cap% Change
Nov 21, 20245.43B-30.23%
Dec 29, 20237.78B94.15%
Dec 30, 20224.01B-21.50%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition